US House panel drops bid to remove FTC’s antitrust authority

Published 04/30/2025, 03:14 PM
Updated 04/30/2025, 04:31 PM
© Reuters. FILE PHOTO: A view of signage at the Federal Trade Commission (FTC) headquarters in Washington, D.C., U.S., November 24, 2024. REUTERS/Benoit Tessier/File Photo

By Jody Godoy

WASHINGTON (Reuters) - The House Judiciary Committee reversed course on a proposal to remove the U.S. Federal Trade Commission’s antitrust authority on Wednesday, days after its Republican leadership included the measure in a budget package.

The House panel led by U.S. Representative Jim Jordan, a Republican, had included the proposal in its budget package on Monday. During a hearing on the package, Jordan offered and the committee passed an amendment that would remove the measure.

The FTC is using its antitrust authority to pursue a Big Tech crackdown supported by President Donald Trump and Vice President JD Vance, including potential probes into whether online platforms have broken the law in limiting conservatives’ speech.

FTC Chairman Andrew Ferguson has said that if companies colluded to set content moderation policies, or if advertisers coordinated boycotts of platforms such as Musk’s X, such actions could violate antitrust law. The FTC is now in the middle of a high-stakes antitrust trial against Meta Platforms (NASDAQ:META). The case brought during Trump’s first term accuses Meta of holding a social media monopoly, which the company denies.

The House Judiciary measure would have shifted the FTC’s antitrust staff and work to the U.S. Department of Justice.

The two agencies have shared federal antitrust jurisdiction, intended to guard against anticompetitive business behavior, for more than 100 years.

The proposal mirrored the One Agency Act, a Republican bill that has gotten support from Elon Musk, the Tesla (NASDAQ:TSLA) CEO leading Trump’s bid to slash the federal workforce.

Critics have said the measure would effectively repeal the FTC’s broad authority to sue companies over unfair methods of competition, which the agency is using in cases against pharmacy benefit managers, Amazon (NASDAQ:AMZN) and John Deere (NYSE:DE).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.